121 related articles for article (PubMed ID: 8019450)
1. Successful purging of murine plasmacytoma by mafosfamide (ASTA-Z).
Weiss L; Slavin G; Reich S; Sidi H; Slavin S
Bone Marrow Transplant; 1994 Jan; 13(1):27-30. PubMed ID: 8019450
[TBL] [Abstract][Full Text] [Related]
2. In vitro purging of bone marrow with mafosfamide synergizes with in vivo chemotherapy to delay the hematological recovery in a murine model of autologous bone marrow transplantation.
Lopez M; Mary JY; Sainteny F
Exp Hematol; 1993 Feb; 21(2):311-8. PubMed ID: 8425567
[TBL] [Abstract][Full Text] [Related]
3. MOPC-315 murine plasmacytoma as a model anticancer screen for human multiple myeloma.
Valeriote F; Grates H
J Natl Cancer Inst; 1986 Jan; 76(1):61-5. PubMed ID: 3455743
[TBL] [Abstract][Full Text] [Related]
4. Effect of mafosfamide (ASTA-Z-7654) on the clonogenic cells in precursor-B acute lymphoblastic leukaemia: significance for ex vivo purging of bone marrow for autologous transplantation.
Makrynikola V; Kabral A; Bradstock KF
Bone Marrow Transplant; 1991 Nov; 8(5):351-5. PubMed ID: 1768969
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic bone marrow purging: is there any place for etoposide? In vitro comparison with mafosfamide.
Olivieri A; Poloni A; Montanari M; Cantori I; Corvatta L; Masia MC; Curzi L; Mancini S; Leoni P
J Hematother; 1997 Apr; 6(2):137-44. PubMed ID: 9131443
[TBL] [Abstract][Full Text] [Related]
6. Preclinical studies of the combination of mafosfamide (Asta-Z 7654) and etoposide (VP-16-213) for purging leukemic autologous marrow.
Tamayo E; Hervé P
Exp Hematol; 1988 Feb; 16(2):97-101. PubMed ID: 3276544
[TBL] [Abstract][Full Text] [Related]
7. Purging of leukemia-contaminated bone marrow grafts using suicide adenoviral vectors: an in vivo murine experimental model.
Garcia-Castro J; Rio P; Lillo R; Garcia-Sanchez F; Segovia JC; Bueren JA
Gene Ther; 2003 Aug; 10(16):1328-35. PubMed ID: 12883529
[TBL] [Abstract][Full Text] [Related]
8. Detection of residual murine LPC-1 myeloma cells from bone marrow cell mixture after purging by 4-hydroperoxycyclophosphamide.
Frondoza CG; Sinha S; Trivedi SM; Humphrey RL; Colvin OM
Exp Hematol; 1987 Jul; 15(6):715-8. PubMed ID: 3297761
[TBL] [Abstract][Full Text] [Related]
9. Recovery of the ability to induce immune resistance against L1210 lymphatic leukemia in semisyngeneic CD2F1 mice after lethal irradiation and reconstitution with bone marrow purged of leukemia with mafosfamide (ASTA Z 7654).
Skórski T; Kawalec M
Bone Marrow Transplant; 1987 Dec; 2(4):435-40. PubMed ID: 3332191
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation.
Casorati G; Locatelli F; Pagani S; Garavaglia C; Montini E; Lisini D; Turin I; Rossi F; Dellabona P; Maccario R; Montagna D
Exp Hematol; 2005 Feb; 33(2):212-8. PubMed ID: 15676215
[TBL] [Abstract][Full Text] [Related]
11. Use and mechanism of action of AS101 in protecting bone marrow colony forming units-granulocyte-macrophage following purging with ASTA-Z 7557.
Kalechman Y; Barkai IS; Albeck M; Horwith G; Sehagl SN; Sredni B
Cancer Res; 1991 Oct; 51(20):5614-20. PubMed ID: 1913679
[TBL] [Abstract][Full Text] [Related]
12. [Bone marrow autotransplantation in acute myeloblastic leukemia in its first complete remission. The clinical results in 41 patients].
Tomás JF; Gómez-García de Soria V; Pinilla I; Lamana M; Figuera A; Arranz R; Cámara R; Fernández-Villalta MJ; Alegre A; Fernández-Rañada JM
Med Clin (Barc); 1997 Feb; 108(6):201-6. PubMed ID: 9102484
[TBL] [Abstract][Full Text] [Related]
13. Induction of tumor-specific antitumor immunity after chemotherapy with cisplatin in mice bearing MOPC-104E plasmacytoma by modulation of MHC expression on tumor surface.
Nio Y; Hirahara N; Minari Y; Iguchi C; Yamasawa K; Toga T; Tamura K
Anticancer Res; 2000; 20(5A):3293-9. PubMed ID: 11062756
[TBL] [Abstract][Full Text] [Related]
14. Purging of murine erythroblastic leukemia by ZnPcS2P2-based-photodynamic therapy.
Huang HF; Chen YZ; Wu Y; Chen P
Bone Marrow Transplant; 2006 Jan; 37(2):213-7. PubMed ID: 16284611
[TBL] [Abstract][Full Text] [Related]
15. Optimization of conditioning therapy for leukemia prior to BMT. I. Optimal synergism between cyclophosphamide and total body irradiation for eradication of murine B cell leukemia (BCL1).
Loewenthal E; Weiss L; Samuel S; Or R; Slavin S
Bone Marrow Transplant; 1993 Aug; 12(2):109-13. PubMed ID: 8401354
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle-based purging of lymphoma cells from bone marrow harvests using radioiodinated 5-iodo-2'-deoxyuridine.
Schneiderman MH; Jackson JD; Joshi SS; Clark-Pierce L; Murphy BJ; Schneiderman GS
Radiat Res; 1998 Feb; 149(2):147-54. PubMed ID: 9457894
[TBL] [Abstract][Full Text] [Related]
17. Prolonged survival after intensive therapy and purged ABMT in patients with multiple myeloma.
Reece DE; Brockington DA; Phillips GL; Barnett MJ; Klingemann HG; Nantel SH; Sutherland HJ; Shepherd JD
Bone Marrow Transplant; 2000 Sep; 26(6):621-6. PubMed ID: 11041567
[TBL] [Abstract][Full Text] [Related]
18. Early induction of immune resistance against leukemia in lethally total body irradiated mice reconstituted with syngeneic bone marrow cells obtained from previously immunized donor mice.
Skorski T; Kawalec M; Kawiak J
Bone Marrow Transplant; 1990 Jan; 5(1):23-7. PubMed ID: 2297588
[TBL] [Abstract][Full Text] [Related]
19. Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamide.
Reece DE; Barnett MJ; Connors JM; Klingemann HG; O'Reilly SE; Shepherd JD; Sutherland HJ; Phillips GL
Bone Marrow Transplant; 1993 Feb; 11(2):139-46. PubMed ID: 8435663
[TBL] [Abstract][Full Text] [Related]
20. ASTA-Z 7557 impairs human natural killer (NK) cell activity.
Condiotti R; Slavin S; Nagler A
Leuk Res; 1996 Feb; 20(2):169-74. PubMed ID: 8628016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
